Lung cancer remains the leading cause of cancer-related deaths worldwide, accounting for nearly one in five cancer deaths - around 1.8 million lives lost each year.
OXFORD, England & TORONTO--(BUSINESS WIRE)--Oxford Cancer Analytics (OXcan), the medtech company developing blood tests for early cancer detection using advanced proteomics and AI, today announced it ...
Survival outcomes in non-small cell lung cancer: Real-world analysis of immunotherapy era vs pre-immunotherapy era, with insights into treatment settings, racial disparities, and socioeconomic impacts ...
Development and Validation of an Ipsilateral Breast Tumor Recurrence Risk Estimation Tool Incorporating Real-World Data and Evidence From Meta-Analyses: A Retrospective Multicenter Cohort Study Data ...
Please provide your email address to receive an email when new articles are posted on . Machine learning models can predict which patients receiving lung cancer therapy may need urgent care visits.
New cfDNA test enables multicancer detection with high accuracy, offering a cost effective approach for early diagnosis and screening.
(PUEBLO, Colo.) — UCHealth Parkview Medical Center said a new robotic biopsy system could detect lung cancer earlier in patients. UCHealth said early detection plays a critical role in improving lung ...
Please provide your email address to receive an email when new articles are posted on . The FDA recently cleared Qure.ai’s qCT LN Quant AI solution for lung nodule management. Early detection, precise ...
MethylScan is a low-cost blood test that detects multiple cancers and liver diseases by analyzing DNA methylation patterns ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results